0.29 USDas of 2026-08-01 11:01 UTC — not live prices
Matinas BioPharma Holdings, Inc. announced a strategic business combination with GH Power to create a publicly traded clean energy and green hydrogen company, and also signed a definitive agreement to sell its LNC Platform Technology and lead product candidate MAT2203 to Azurity Pharmaceuticals.
Prices and news are refreshed on a schedule, not live. Findings cite their source documents. Informational only — not investment advice. Explore the full research platform →